- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Nicole Rosendale Says Data Collection Is Step 1 for Value-Based Care in the Neurology Space for LGBTQ+ Individuals
Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist, talks about how data on the LGBTQ+ community in the neurology space is needed in order to provide effective value-based health care.
More data is needed in order to provide true value-based care to LGBTQ+ community memebers, says Nicole Rosendale, MD, assistant professor of neurology at the University of California San Francisco, neurologist/neurohospitalist.
Transcript
How can value-based health care methods help the LGBTQ+ community in the neurology space?
This is such an important question, and I think the idea of value-based care has a lot of momentum behind it. The challenge is that value-based care requires data. It requires measurement of outcomes; reporting back continual iteration of the process to improve the quality of care. The challenge is with that measurement piece, and so not very many folks collect sexual orientation or gender identity in their data routinely. So, we don't have that first part; we don't have the data to go into the process, to talk about outcomes, to talk about how we can do better for service for the community and access and outcomes within care. So, I think that really working on that first step is going to hopefully drive us towards be able to actually provide value-based care for LGBTQ individuals.
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
